Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
309.90    0.50 (0.16%)
Bid:
309.90
Ask:
310.10
Spread: 0.20 (0.065%)
Market Cap: £6.86b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

Form 8.5 (EPT/RI)

1 Sep 2016 12:00

RNS Number : 7148I
UBS AG (EPT)
01 September 2016
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

UBS Investment Bank, London

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

J Sainsbury Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

J Sainsbury Plc offeror to Home Retail Group Plc

(d) Date dealing undertaken:

31 August 2016

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

Home Retail Group Plc

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

28 4/7p ordinary

Buy

Β 

8674789

2.42750 GBP

2.38400 GBP

28 4/7p ordinary

Sell

Β 

10106839

2.42750 GBP

2.39723 GBP

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

28 4/7p ordinary

CFD

Β 

Long

122742

2.414626 GBP

28 4/7p ordinary

CFD

Β 

Long

446133

2.403Β GBP

28 4/7p ordinary

CFD

Β 

Long

2500

2.413623 GBP

28 4/7p ordinary

CFD

Β 

Long

7736

2.40227896 GBP

28 4/7p ordinary

CFD

Β 

Long

27167

2.41483785 GBP

28 4/7p ordinary

CFD

Β 

Long

66817

2.4114058 GBP

28 4/7p ordinary

CFD

Β 

Long

400000

2.4027597 GBP

28 4/7p ordinary

CFD

Β 

Long

179914

2.41199643 GBP

28 4/7p ordinary

CFD

Β 

Long

144971

2.400222 GBP

28 4/7p ordinary

CFD

Β 

Long

137399

2.415279 GBP

28 4/7p ordinary

CFD

Β 

Long

39802

2.417702 GBP

28 4/7p ordinary

CFD

Β 

Long

100525

2.417388 GBP

28 4/7p ordinary

CFD

Β 

Long

10500

2.417333 GBP

28 4/7p ordinary

CFD

Β 

Short

13385

2.392585 GBP

28 4/7p ordinary

CFD

Β 

Short

7451

2.403 GBP

28 4/7p ordinary

CFD

Β 

Short

2338

2.422Β GBP

28 4/7p ordinary

CFD

Β 

Short

4283

2.409739 GBP

28 4/7p ordinary

CFD

Β 

Short

1800

2.384Β GBP

28 4/7p ordinary

CFD

Β 

Short

12840

2.413761 GBP

28 4/7p ordinary

CFD

Β 

Short

1500

2.389067 GBP

28 4/7p ordinary

CFD

Β 

Short

53401

2.41083 GBP

28 4/7p ordinary

CFD

Β 

Short

12000

2.420992 GBP

28 4/7p ordinary

CFD

Β 

Short

4400

2.410849 GBP

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

Date of disclosure:

01 September 2016

Contact name:

Tahmidul Haque

Telephone number:

+44 (0)20 7568 1245

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEREAENFESPKEFF
Date   Source Headline
22nd Feb 202410:45 amRNSChange of Auditor
19th Feb 20243:15 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSSainsbury’s Strategy Update
1st Feb 202410:30 amRNSBlock listing Interim Review
1st Feb 202410:15 amRNSTotal Voting Rights
22nd Jan 20249:15 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSStrategic review of Financial Services division
10th Jan 20247:00 amRNSTrading Statement
2nd Jan 202411:30 amRNSTotal Voting Rights
28th Dec 20234:00 pmRNSHolding(s) in Company
22nd Dec 202311:30 amRNSDirector/PDMR Shareholding
18th Dec 20232:00 pmRNSHolding(s) in Company
15th Dec 202311:55 amRNSDirector/PDMR Shareholding
1st Dec 202311:00 amRNSTotal Voting Rights
24th Nov 20231:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20234:20 pmRNSDirector Declaration
2nd Nov 20237:00 amRNSHalf-year Report
1st Nov 20231:10 pmRNSTotal Voting Rights
27th Oct 202312:15 pmRNSDirector/PDMR Shareholding
13th Oct 202312:35 pmRNSHolding(s) in Company
2nd Oct 20231:40 pmRNSTotal Voting Rights
1st Sep 20231:00 pmRNSDirector/PDMR Shareholding
1st Sep 202312:15 pmRNSTotal Voting Rights
11th Aug 20232:45 pmRNSSainsbury’s Bank sells mortgage portfolio
4th Aug 20233:45 pmRNSDirector/PDMR Shareholding
3rd Aug 20233:45 pmRNSDirector/PDMR Shareholding
1st Aug 20233:30 pmRNSBlock listing Interim Review
1st Aug 20232:30 pmRNSTotal Voting Rights
27th Jul 202312:00 pmRNSDirector/PDMR Shareholding
27th Jul 202312:00 pmRNSAdditional Listing
7th Jul 20232:35 pmRNSDirector/PDMR Shareholding
6th Jul 20232:15 pmRNSResult of AGM
4th Jul 20237:00 amRNSTrading Statement
3rd Jul 20231:45 pmRNSTotal Voting Rights
30th Jun 202312:30 pmRNSDirector Declaration
15th Jun 20231:33 pmRNSDirector/PDMR Shareholding
12th Jun 20232:50 pmRNSDirector/PDMR Shareholding
6th Jun 20233:55 pmRNSDirector/PDMR Shareholding
6th Jun 20233:40 pmRNSAnnual Report and Notice of AGM 2023
1st Jun 202312:20 pmRNSTotal Voting Rights
12th May 20233:30 pmRNSHolding(s) in Company
12th May 20231:30 pmRNSDirector/PDMR Shareholding
10th May 20233:30 pmRNSDirector/PDMR Shareholding
9th May 20234:00 pmRNSDirector/PDMR Shareholding
2nd May 20234:15 pmRNSDirector/PDMR Shareholding
2nd May 20233:45 pmRNSTotal Voting Rights
27th Apr 20237:00 amRNSFinal Results
14th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:25 pmRNSTotal Voting Rights
17th Mar 20232:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.